Rothschild Investment Corp Charles River Laboratories International, Inc. Transaction History

Rothschild Investment Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$222.0 - $252.62 $398,268 - $453,200	-1,794 Closed	0 $0
Q3 2020 Oct 22, 2020	BUY	$175.56 - $226.45 $81,459 - $105,072	464 Added 34.89%	1,794 $407,000
Q2 2020 Jul 24, 2020	SELL	$118.84 - $189.72 $56,449 - $90,117	-475 Reduced 26.32%	1,330 $232,000
Q1 2020 Apr 16, 2020	BUY	$98.9 - $178.34 $12,461 - $22,470	126 Added 7.5%	1,805 $228,000
Q4 2019 Jan 22, 2020	BUY	$126.05 - $152.76 $211,637 - $256,484	1,679 New	1,679 $256,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

Stay updated on Rothschild Investment Corp with notifications on news.